Navigation Links
ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy

By knowing a patient's PDx Index(TM) score ahead of time, the physician can prescribe the right drug treatment that has the highest probability of success for that individual."

About ApoCell, Inc.

ApoCell was founded in 2004 to commercialize biomarker technologies that were developed at the University of Texas M.D. Anderson Cancer Center. This proprietary method monitors the effectiveness of cancer drugs by measuring biomarker expression patterns in patient specimens. ApoCell provides analytical biomarker services to pharmaceutical and biotechnology companies, and clinical researchers in academia and government to assist them in developing new therapeutic agents. ApoCell's technology has been tested in 38 clinical studies with over 11,000 specimens on 28 investigational drugs including six FDA approved cancer drugs. ApoCell's molecular-based diagnostics have application in oncology and other diseases. For more information, please visit www.apocell.com.

Contact

ApoCell, Inc., Houston
Darren Davis, 713-440-6070


'"/>




Page: 1 2

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression

Post Your Comments:
(Date:11/6/2009)...e-FirstCall/ -- Derma Sciences, Inc. (OTC Bull...re products, announced plans to release its third ...mber 16, 2009. The Company will hold a conference ... am EST. Interested parties should call (866) 788-... with passcode 81416481 to access the call. You ma...
(Date:11/6/2009)...-FirstCall/ -- Virtual Health Technologies, Inc. (... previously confirmed Letter of Intent to sell all...chnologies, Inc (WNDM) is subject to final approva...HGI. ,, Shareholder Assurances ,, "We be...tream and cash realized from the transaction would...
(Date:11/6/2009)...Call/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: ...ember 10, 2009 at 8:30 a.m. EST to discuss the thi...look for the remainder of 2009. Ron Bentsur, Chie...call. Keryx will announce its financial results f...or to the call. ,, In order to participate in t...
Breaking Medicine Technology:Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Survey Demonstrates Marin County Residents Support Locally Owned and Operated Marin General Hospital 54452 1Survey Demonstrates Marin County Residents Support Locally Owned and Operated Marin General Hospital 54452 2St Jude Appoints New Senior Vice President of Public Relations 54447 1St Jude Appoints New Senior Vice President of Public Relations 54447 2Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48 Year Exemplary Record of Quality 54443 1Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48 Year Exemplary Record of Quality 54443 2
...Risk of death at five years is lower for aneurysm ...o surgical clipping , , NATICK, Mass., May 26 Bo...elcomed publication of results from the ISAT clini... with a ruptured intracranial aneurysm treated wit...ss likely to die within five years compared to pat...
...Data Confirm Tapentadol Efficacy and Tolerability ... It is estimated that up to 30 percent of all peo...ide effects, such as nausea and vomiting. The use ...is a leading risk factor for experiencing these si...and bothersome and can have an impact on a patient...
Other Medicine Technology:Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 2Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 3Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
(Date:11/6/2009)..., Nov. 6 The U.S. Department of Veterans Affairs ...,s capital to signal the beginning of a new missio...five years. ,, More than 1,300 VA clinicians and h... agencies invested in providing support for homele...th-based service providers represented by the Nati...
(Date:11/6/2009)...on Will Help Hundreds of Thousands of Idahoans Str...aring Insurance Premiums ,, BOISE, Idaho, Nov. 6...a fevered pitch and the House readies to vote on c...ng days - AARP is calling on Idaho,s U.S. Represen...rdable Health Care for America Act (H.R. 3962), wh...
(Date:11/6/2009)...T, Ill., Nov. 6 Hospira, Inc. (NYSE: HSP ), a le...on delivery company, today announced that the comp...Health Care Conference on Wednesday, Dec. 2, 2009 ... to begin at 9:30 a.m. Eastern time on Wednesday, ...ted parties through a live audiocast accessible vi...
(Date:11/6/2009)... A survey released today from Jackso...ns surveyed (74 percent) feel they have less contr...id five years ago. , Alph...leased today from Jackson Healthcare reports tha... feel they have less control over the way they pra...
(Date:11/6/2009)...armacy, clinic and government programs, expert say...he recession has made it more difficult than ever ...edications, but several options are available, acc...anapolis. , First, talk to your pharmacist, advise...ant professor of pharmacy practice at Butler,s Col...
Breaking Medicine News(10 mins):Health News:VA Summit Frames Plan to End Veteran Homelessness 2Health News:AARP Calls On Idaho's U.S. Reps To Back House Health Care Reform Bill 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4Health News: Pay Less for Prescription Drugs 2
...merican Psychoanalytic,Association (APsaA) denounc...ed Proposition 8, a ballot measure that bans same-...rall support of social justice, APsaA,issued a pos...For the full text of the APsaA Marriage,Resolution...
...mong sufferers may be the reason why, researchers ...-- Women who experience migraines may actually hav...cer, say researchers from the Fred Hutchinson Canc...of breast cancer, but women who suffer migraines a...
...udgets Negatively Impacted by High Sodium Foods, ...O, Wash., Nov. 6 Salt. It,s been a hot topic,shak... years, and now it,s,making waves at the governmen...ubstantially more than the USDA recommendation,of ...
...will help meet increasing demand for,pharmaceutica...neywell (NYSE: HON ) announced,today that it has ...,Haishun Packaging Material Co., Ltd., to provide ...ces and training to Haishun,as part of the agreeme...
...ndent factor in cancer survival rates and should n...tients, according to a study in the November issue...ractice . , A team of hospital and University-bas...mber of factors that influence survival rates inc...
...rnational Conference on Cell Therapy for Cardiovas...program dedicated to the evolving field of cell-ba.... The theme of this year,s meeting is "Cellular an...iscussions on stem cell science as well as their w...
Other Medicine News:Health News:Psychoanalysts Censure California's Vote to Ban Same-Sex Marriage 2Health News:Migraine Might Lower Breast Cancer Risk 2Health News:Migraine Might Lower Breast Cancer Risk 3Health News:Spare Us the Salt! Oregonians Paying a Hefty Price for Hidden Salt 2Health News:Spare Us the Salt! Oregonians Paying a Hefty Price for Hidden Salt 3Health News:Spare Us the Salt! Oregonians Paying a Hefty Price for Hidden Salt 4Health News:Honeywell Signs Supply Agreement with Chinese Company for Aclar(R) Film 2Health News:Honeywell Signs Supply Agreement with Chinese Company for Aclar(R) Film 3Health News:Age is not a key factor in cancer survival, but clinical trials exclude older patients 2Health News:Age is not a key factor in cancer survival, but clinical trials exclude older patients 3Health News:5th Annual Global Conference on Stem Cell Therapy to be held Jan. 13-16, 2009 in NYC 2
...r, Model II, is very simple to use and, furthermor...ned because it is only necessary to coincide the s...cales then indicating the pupillary distance, as w...nts between the centers of spectacle lenses and th...
...reenoscope provides fast, accurate, and reliable t... optical system duplicates conditions for viewing ...es conditions for near point test charts at 30cm (...ncorporates test charts that can be interchanged a...
...ce into the future with the all-new EXAM-3000! Per...fficiency, dramatically increase your patient flow...money. Todays demand for delegation and connectivi...or the progressive practice. Compare the new EXAM-...
Topcon OM-4 Ophthalmometer
Medicine Products: